2% chlorhexidine gluconate aqueous versus 2% chlorhexidine gluconate in 70% isopropyl alcohol for skin disinfection prior to percutaneous central venous catheterisation: the ARCTIC randomised controlled feasibility trial
Authors:
- Paul ClarkePCPaul Clarke
- Aung SoeASAung Soe
- Amy NicholsANAmy Nichols
- Helen HarizajHHHelen Harizaj
- Mark A WebberMWMark A Webber
- Louise LinsellLLLouise Linsell
- Jennifer L BellJBJennifer L Bell
- Catherine TremlettCTCatherine Tremlett
- Priyadarsini MuthukumarPMPriyadarsini Muthukumar
- Santosh PattnayakSPSantosh Pattnayak
- Christopher PartlettCPChristopher Partlett
- Andrew KingAKAndrew King
Open Access
- 31 October 2023
- journal article
- research article
- Published by BMJ in Archives of Disease in Childhood - Fetal and Neonatal Edition
- Vol. 109 (2) , 202-210
Abstract
Objective Catheter-related sepsis (CRS) is a major complication with significant morbidity and mortality. Evidence is lacking regarding the most appropriate antiseptic for skin disinfection before percutaneous central venous catheter (PCVC) insertion in preterm neonates. To inform the feasibility and design of a definitive randomised controlled trial (RCT) of two antiseptic formulations, we conducted the Antiseptic Randomised Controlled Trial for Insertion of Catheters (ARCTIC) feasibility study to assess catheter colonisation, sepsis, and skin morbidity. Design Feasibility RCT. Setting Two UK tertiary-level neonatal intensive care units. Patients Preterm infants born Interventions Skin disinfection with either 2% chlorhexidine gluconate (CHG)-aqueous or 2% CHG-70% isopropyl alcohol (IPA) before PCVC insertion and at removal. Primary outcome Proportion in the 2% CHG-70% IPA arm with a colonised catheter at removal. Main feasibility outcomes Rates of: (1) CRS, catheter-associated sepsis (CAS), and CRS/CAS per 1,000 PCVC days; (2) recruitment and retention; (3) data completeness. Safety outcomes Daily skin morbidity scores recorded from catheter insertion until 48 hours post-removal. Results 116 babies were randomised. Primary outcome incidence was 4.1% (95% confidence interval: 0.9% to 11.5%). Overall catheter colonisation rate was 5.2% (5/97); CRS 2.3/1000 catheter days; CAS 14.8/1000 catheter days. Recruitment, retention and data completeness were good. No major antiseptic-related skin injury was reported. Conclusions A definitive comparative efficacy trial is feasible, but the very low catheter colonisation rate would make a large-scale RCT challenging due to the very large sample size required. ARCTIC provides preliminary reassurance supporting potential safe use of 2% CHG-70% IPA and 2% CHG-aqueous in preterm neonates. Trial registration number ISRCTN82571474.Keywords
Funding Information
- Research for Patient Benefit Programme (PB-PG-1013-32076)
This publication has 27 references indexed in Scilit:
- Skin antisepsis in the neonateCurrent Opinion in Infectious Diseases, 2014
- epic3: National Evidence-Based Guidelines for Preventing Healthcare-Associated Infections in NHS Hospitals in EnglandJournal of Hospital Infection, 2014
- The hidden harms of Matching MichiganArchives of Disease in Childhood - Fetal and Neonatal Edition, 2013
- Devastating coagulase-negative staphylococcal septicaemia in an extremely low birth weight infantBMJ Case Reports, 2012
- Postnatal infection is associated with widespread abnormalities of brain development in premature newbornsPediatric Research, 2012
- Segmental percutaneous central venous line cultures for diagnosis of catheter-related sepsisArchives of Disease in Childhood - Fetal and Neonatal Edition, 2011
- epic2: National Evidence-Based Guidelines for Preventing Healthcare-Associated Infections in NHS Hospitals in EnglandJournal of Hospital Infection, 2007
- Neurodevelopmental and Growth Impairment Among Extremely Low-Birth-Weight Infants With Neonatal InfectionJAMA, 2004
- Chlorhexidine Compared with Povidone-Iodine Solution for Vascular Catheter–Site CareAnnals of Internal Medicine, 2002
- A Semiquantitative Culture Method for Identifying Intravenous-Catheter-Related InfectionNew England Journal of Medicine, 1977